Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Koolen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
JACC. Cardiovascular Imaging|March 24, 2017
Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded ArteriesYaping Zeng, Hiroki Tateishi, Rafael Cavalcante, et al.
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 14, 2019
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-StudyAlexandre Hideo-Kajita, Hector M Garcia-Garcia, Michael Haude, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
JACC. Cardiovascular Imaging|March 24, 2017
Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded ArteriesYaping Zeng, Hiroki Tateishi, Rafael Cavalcante, et al.
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality studyJohn A Ormiston, Patrick W Serruys, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|December 20, 2014
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Patrick W Serruys, Takashi Muramatsu, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2013
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 monthsPatrick W Serruys, Yoshinobu Onuma, Hector M Garcia-Garcia, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|July 23, 2011
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-upJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 14, 2019
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-StudyAlexandre Hideo-Kajita, Hector M Garcia-Garcia, Michael Haude, et al.
Pageof 6